171 related articles for article (PubMed ID: 6311913)
1. Immunogenicity of a Haemophilus influenzae type b vaccine in combination with diphtheria-pertussis-tetanus vaccine in infants.
Coulehan JL; Hallowell C; Michaels RH; Welty TK; Lui N; Kuo JS
J Infect Dis; 1983 Sep; 148(3):530-4. PubMed ID: 6311913
[TBL] [Abstract][Full Text] [Related]
2. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.
Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS
J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid.
Käyhty H; Eskola J; Peltola H; Stout MG; Samuelson JS; Gordon LK
J Infect Dis; 1987 Jan; 155(1):100-6. PubMed ID: 3491858
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
5. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.
Ferreccio C; Clemens J; Avendano A; Horwitz I; Flores C; Avila L; Cayazzo M; Fritzell B; Cadoz M; Levine M
Pediatr Infect Dis J; 1991 Oct; 10(10):764-71. PubMed ID: 1945579
[TBL] [Abstract][Full Text] [Related]
6. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.
Clemens JD; Ferreccio C; Levine MM; Horwitz I; Rao MR; Edwards KM; Fritzell B
JAMA; 1992 Feb; 267(5):673-8. PubMed ID: 1731134
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a new Haemophilus influenzae type b vaccine in infants under one year of age.
King SD; Ramlal A; Wynter H; Moodie K; Castle D; Kuo JS; Barnes L; Williams CL
Lancet; 1981 Oct; 2(8249):705-9. PubMed ID: 6116855
[TBL] [Abstract][Full Text] [Related]
10. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
Huu TN; Phuong NT; Toan NT; Thang HV
Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
[TBL] [Abstract][Full Text] [Related]
11. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
[TBL] [Abstract][Full Text] [Related]
12. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants.
Watemberg N; Dagan R; Arbelli Y; Belmaker I; Morag A; Hessel L; Fritzell B; Bajard A; Peyron L
Pediatr Infect Dis J; 1991 Oct; 10(10):758-63. PubMed ID: 1945578
[TBL] [Abstract][Full Text] [Related]
14. Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine.
Anderson P; Pichichero M; Edwards K; Porch CR; Insel R
J Pediatr; 1987 Nov; 111(5):644-50. PubMed ID: 3499499
[TBL] [Abstract][Full Text] [Related]
15. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
Gordon LK
Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.
Halsey NA; Johansen TL; Bowman LC; Glode MP
Infect Immun; 1983 Mar; 39(3):1196-200. PubMed ID: 6601621
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
18. Antibody responses to a combination vaccine against Haemophilus influenzae type b, diphtheria, pertussis, and tetanus.
Moxon ER; Anderson P; Smith DH; Blanca Adrianzen T; Graham GG; Baker RS
Bull World Health Organ; 1975; 52(1):87-90. PubMed ID: 174825
[TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
[TBL] [Abstract][Full Text] [Related]
20. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
